198 related articles for article (PubMed ID: 8741824)
1. Early atherogenesis in diabetes mellitus.
Schaper NC
Diabet Med; 1996; 13 Suppl 1():S23-5. PubMed ID: 8741824
[No Abstract] [Full Text] [Related]
2. Current concepts and controversies in the pathogenesis, prevention, and treatment of the macrovascular complications of diabetes.
Mazzone T
J Lab Clin Med; 2000 Jun; 135(6):437-43. PubMed ID: 10850642
[No Abstract] [Full Text] [Related]
3. Fibrinogen, fibrinolysis and diabetes mellitus: a comment.
Vague P; Juhan-Vague I
Diabetologia; 1997 Jun; 40(6):738-40. PubMed ID: 9222657
[No Abstract] [Full Text] [Related]
4. Endothelial dysfunction, atherosclerosis and diabetes.
Najemnik C; Sinzinger H; Kritz H
Acta Med Austriaca; 1999; 26(5):148-53. PubMed ID: 11512191
[TBL] [Abstract][Full Text] [Related]
5. Fibrinogen and diabetes mellitus: is it time for intervention trials?
Ceriello A
Diabetologia; 1997 Jun; 40(6):731-4. PubMed ID: 9222655
[No Abstract] [Full Text] [Related]
6. Hypertriglyceridemia and its metabolic consequences as a risk factor for atherosclerotic cardiovascular disease in non-insulin-dependent diabetes mellitus.
Lewis GF; Steiner G
Diabetes Metab Rev; 1996 Apr; 12(1):37-56. PubMed ID: 8861500
[No Abstract] [Full Text] [Related]
7. Dyslipidaemia in diabetes mellitus. Review of the main lipoprotein abnormalities and their consequences on the development of atherogenesis.
Vergès BL
Diabetes Metab; 1999 Jun; 25 Suppl 3():32-40. PubMed ID: 10421991
[TBL] [Abstract][Full Text] [Related]
8. [Prevention of arteriosclerosis with the insulin sensitizer pioglitazone. Early intervention in diabetic patients compensates "cell ignorance"].
MMW Fortschr Med; 2002 May; 144(21):52-3. PubMed ID: 12134427
[No Abstract] [Full Text] [Related]
9. Advanced glycation end-products in diabetes mellitus, with particular reference to angiopathy.
Chiarelli F; Mansour M; Verrotti A
Diabetes Nutr Metab; 2000 Aug; 13(4):192-9. PubMed ID: 10961486
[No Abstract] [Full Text] [Related]
10. [Vascular complications in diabetes mellitus: role of endothelial dysfunction].
Stehouwer CD
Ned Tijdschr Geneeskd; 1996 Apr; 140(16):870-4. PubMed ID: 8692297
[No Abstract] [Full Text] [Related]
11. New advances in the management of insulin resistance in type 2 diabetes. Introduction.
Campbell IW; Charbonnel B
Int J Clin Pract Suppl; 2001 Sep; (121):3. PubMed ID: 11594242
[No Abstract] [Full Text] [Related]
12. Involvement of semicarbazide-sensitive amine oxidase-mediated deamination in atherogenesis in KKAy diabetic mice fed with high cholesterol diet.
Yu PH; Wang M; Deng YL; Fan H; Shira-Bock L
Diabetologia; 2002 Sep; 45(9):1255-62. PubMed ID: 12242458
[TBL] [Abstract][Full Text] [Related]
13. [Arterial hypertension and diabetes mellitus].
Charbonnel B; Mimran A
Diabete Metab; 1992; 18(2 Pt 2):127-8. PubMed ID: 1639202
[No Abstract] [Full Text] [Related]
14. [Control of atherosclerosis in diabetes mellitus].
Quiroz Martínez A
Arch Cardiol Mex; 2003; 73 Suppl 1():S125-7. PubMed ID: 12966662
[TBL] [Abstract][Full Text] [Related]
15. When to treat the hypertensive diabetic patient.
Fuller JH
J Diabetes Complications; 1996; 10(3):144-5. PubMed ID: 8807461
[No Abstract] [Full Text] [Related]
16. Modification of lipoproteins in diabetes.
Lopes-Virella MF; Klein RL; Virella G
Diabetes Metab Rev; 1996 Apr; 12(1):69-90. PubMed ID: 8861502
[No Abstract] [Full Text] [Related]
17. Atherosclerosis, the major complication of diabetes.
Steiner G
Adv Exp Med Biol; 1985; 189():277-97. PubMed ID: 4036715
[No Abstract] [Full Text] [Related]
18. [Type 2 diabetes and large vessel disease].
Segal P
Diabetes Metab; 1999 Dec; 25 Suppl 7():7-10. PubMed ID: 10746003
[TBL] [Abstract][Full Text] [Related]
19. Insulin resistance and atherosclerosis.
Garg A; Haffner SM
Diabetes Care; 1996 Mar; 19(3):274. PubMed ID: 8742581
[No Abstract] [Full Text] [Related]
20. Natural history of macrovascular disease in type 2 diabetes. Role of insulin resistance.
Stern M
Diabetes Care; 1999 Apr; 22 Suppl 3():C2-5. PubMed ID: 10189555
[No Abstract] [Full Text] [Related]
[Next] [New Search]
